A primary care guide to stroke secondary prevention: 2021 AHA/ASA guideline, DAPT timing, statin targets, and AFib anticoagulation.
Stroke and TIA Secondary Prevention: A 2026 Primary Care Guide to the AHA/ASA Guideline Read More »
By Dr. Anush Pillai, DO, FAAFP | Reviewed by CME Travel Academy Faculty · 6 min read · Reviewed June 2026 Accredited CME: ✓ AAFP Prescribed ✓ AMA PRA Category 1 Credit™ ✓ AOA Category 2 ✓ 12 Credits per Conference A good family medicine conference does two things at once: it
Family Medicine Conference 2026: A Clinician’s Guide Read More »
By Dr. Vimal George, MD | Reviewed by CME Travel Academy Faculty · 7 min read · Reviewed June 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released its 2026
GOLD 2026 COPD Guidelines: Key Changes for Clinicians Read More »
By Dr. Vimal George, MD | Reviewed by CME Travel Academy Faculty · 7 min read · Reviewed June 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference Most clinicians choose a CME provider the way they pick a flight:
Master the 2022 AHA/ACC/HFSA heart failure guidelines for primary care — ARNI, beta-blocker, MRA, SGLT2i, and new HFpEF therapies including SGLT2 inhibitors and GLP-1 receptor agonists. Earn CME credits.
New CME reporting rules for 2026: real-time tracking, CE Broker pre-verification, Texas SB 912 and the DEA MATE Act — plus a clinician compliance checklist.
KDIGO 2024, the four pillars, and the FLOW & CONFIDENCE trials — what primary care needs to do differently for chronic kidney disease.
Chronic Kidney Disease in Primary Care: The Four Pillars of Kidney Protection Read More »
The 2026 ADA Standards of Care and AACE Type 2 Diabetes Algorithm: earlier CGM, comorbidity-first therapy, and weight targets every clinician should know.
Diabetes Guidelines 2026: The ADA and AACE Updates Every Clinician Needs Read More »
For years, the conversation around GLP-1 receptor agonists in type 2 diabetes centered almost entirely on glucose lowering. Then came a series of landmark cardiovascular outcomes trials — LEADER, SUSTAIN-6, PIONEER 6 — and the paradigm began to shift. But until recently, one practical barrier remained: most GLP-1 receptor agonists required subcutaneous injection, limiting uptake
If you’re a physician, nurse practitioner, or physician assistant attending continuing medical education conferences or completing online CME courses, you may be leaving money on the table at tax time. CME expenses are among the most legitimate — and most overlooked — tax deductions available to healthcare professionals. This guide breaks down exactly what qualifies
CME Tax Deduction Guide for Physicians in 2026: What You Can (and Can’t) Deduct Read More »
